Brittany N Kuhn1, Marin S Klumpner2, Ignacio R Covelo2, Paolo Campus2, Shelly B Flagel3,4,5. 1. Neuroscience Graduate Program, University of Michigan, 4137 Undergraduate Science Building, 204 Washtenaw Avenue, Ann Arbor, MI, 48109, USA. 2. Department of Psychiatry, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI, 48105, USA. 3. Neuroscience Graduate Program, University of Michigan, 4137 Undergraduate Science Building, 204 Washtenaw Avenue, Ann Arbor, MI, 48109, USA. sflagel@umich.edu. 4. Department of Psychiatry, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI, 48105, USA. sflagel@umich.edu. 5. Molecular and Behavioral Neuroscience Institute, University of Michigan, 205 Zina Pitcher Place, Ann Arbor, MI, 48109, USA. sflagel@umich.edu.
Abstract
RATIONALE: The paraventricular nucleus of the thalamus (PVT) has been shown to mediate cue-motivated behaviors, such as sign- and goal-tracking, as well as reinstatement of drug-seeking behavior. However, the role of the PVT in mediating individual variation in cue-induced drug-seeking behavior remains unknown. OBJECTIVES: This study aimed to determine if inactivation of the PVT differentially mediates cue-induced drug-seeking behavior in sign-trackers and goal-trackers. METHODS: Rats were characterized as sign-trackers (STs) or goal-trackers (GTs) based on their Pavlovian conditioned approach behavior. Rats were then exposed to 15 days of cocaine self-administration, followed by a 2-week forced abstinence period and then extinction training. Rats then underwent tests for cue-induced reinstatement and general locomotor activity, prior to which they received an infusion of either saline (control) or baclofen/muscimol (B/M) to inactivate the PVT. RESULTS: Relative to control animals of the same phenotype, GTs show a robust increase in cue-induced drug-seeking behavior following PVT inactivation, whereas the behavior of STs was not affected. PVT inactivation did not affect locomotor activity in either phenotype. CONCLUSION: In GTs, the PVT appears to inhibit the expression of drug-seeking, presumably by attenuating the incentive value of the drug cue. Thus, inactivation of the PVT releases this inhibition in GTs, resulting in an increase in cue-induced drug-seeking behavior. PVT inactivation did not affect cue-induced drug-seeking behavior in STs, suggesting that the role of the PVT in encoding the incentive motivational value of drug cues differs between STs and GTs.
RATIONALE: The paraventricular nucleus of the thalamus (PVT) has been shown to mediate cue-motivated behaviors, such as sign- and goal-tracking, as well as reinstatement of drug-seeking behavior. However, the role of the PVT in mediating individual variation in cue-induced drug-seeking behavior remains unknown. OBJECTIVES: This study aimed to determine if inactivation of the PVT differentially mediates cue-induced drug-seeking behavior in sign-trackers and goal-trackers. METHODS:Rats were characterized as sign-trackers (STs) or goal-trackers (GTs) based on their Pavlovian conditioned approach behavior. Rats were then exposed to 15 days of cocaine self-administration, followed by a 2-week forced abstinence period and then extinction training. Rats then underwent tests for cue-induced reinstatement and general locomotor activity, prior to which they received an infusion of either saline (control) or baclofen/muscimol (B/M) to inactivate the PVT. RESULTS: Relative to control animals of the same phenotype, GTs show a robust increase in cue-induced drug-seeking behavior following PVT inactivation, whereas the behavior of STs was not affected. PVT inactivation did not affect locomotor activity in either phenotype. CONCLUSION: In GTs, the PVT appears to inhibit the expression of drug-seeking, presumably by attenuating the incentive value of the drug cue. Thus, inactivation of the PVT releases this inhibition in GTs, resulting in an increase in cue-induced drug-seeking behavior. PVT inactivation did not affect cue-induced drug-seeking behavior in STs, suggesting that the role of the PVT in encoding the incentive motivational value of drug cues differs between STs and GTs.
Entities:
Keywords:
Cocaine; Goal-tracker; Individual variation; Paraventricular nucleus of the thalamus; Reinstatement; Relapse; Reward cue; Sign-tracker
Authors: Morgan H James; Janine L Charnley; Emma Jones; Emily M Levi; Jiann Wei Yeoh; Jamie R Flynn; Douglas W Smith; Christopher V Dayas Journal: PLoS One Date: 2010-09-23 Impact factor: 3.240
Authors: Benjamin T Saunders; Elizabeth G O'Donnell; Elyse L Aurbach; Terry E Robinson Journal: Neuropsychopharmacology Date: 2014-06-04 Impact factor: 7.853
Authors: Hans S Crombag; Jennifer M Bossert; Eisuke Koya; Yavin Shaham Journal: Philos Trans R Soc Lond B Biol Sci Date: 2008-10-12 Impact factor: 6.237
Authors: James M Otis; ManHua Zhu; Vijay M K Namboodiri; Cory A Cook; Oksana Kosyk; Ana M Matan; Rose Ying; Yoshiko Hashikawa; Koichi Hashikawa; Ivan Trujillo-Pisanty; Jiami Guo; Randall L Ung; Jose Rodriguez-Romaguera; E S Anton; Garret D Stuber Journal: Neuron Date: 2019-06-10 Impact factor: 17.173
Authors: Lauren D Krueger; Stephen E Chang; Michael Motoc; Maurice Chojecki; Zachary T Freeman; Shelly B Flagel Journal: J Am Assoc Lab Anim Sci Date: 2021-04-16 Impact factor: 1.232
Authors: Joshua L Haight; Paolo Campus; Cristina E Maria-Rios; Allison M Johnson; Marin S Klumpner; Brittany N Kuhn; Ignacio R Covelo; Jonathan D Morrow; Shelly B Flagel Journal: Psychopharmacology (Berl) Date: 2020-08-27 Impact factor: 4.530
Authors: Janna M Colaizzi; Shelly B Flagel; Michelle A Joyner; Ashley N Gearhardt; Jennifer L Stewart; Martin P Paulus Journal: Neurosci Biobehav Rev Date: 2020-01-20 Impact factor: 8.989
Authors: Paolo Campus; Ignacio R Covelo; Youngsoo Kim; Aram Parsegian; Brittany N Kuhn; Sofia A Lopez; John F Neumaier; Susan M Ferguson; Leah C Solberg Woods; Martin Sarter; Shelly B Flagel Journal: Elife Date: 2019-09-10 Impact factor: 8.140
Authors: Giuseppe Giannotti; Sarah M Barry; Ben M Siemsen; Jamie Peters; Jacqueline F McGinty Journal: J Neurosci Date: 2018-09-05 Impact factor: 6.167